About Truveris
Truveris is a Healthcare company based in New York (United States) founded in 2009. Truveris has raised $68.7 million across 7 funding rounds from investors including New Leaf Venture Partners, Canaan and McKesson Ventures. The company has 156 employees. Its chief executive, as recorded, is Garrett W. Fienberg. Truveris offers products and services including Truveris Marketplace and truGuard. Its focus areas include HealthTech, Healthcare Payer Tech and Pharmacy Benefit Management. Its legal entity is TRUVERIS INC. Its competitors include Express Scripts, Prescryptive Health and MedImpact Healthcare Systems; 1 of its 3 listed competitors has raised funding.
Company details
HealthTech Analytics and Validation platform. A health information technology company delivering pharmacy data validation, analytics, and pricing solutions through a SaaS platform. Truveris products include TruGuard (claim validation), TruBid (online auction and RFP tool), and TruReport (prescription claim analytics). They also have a product called rxDash RxDash which is a pharmacy plan modeling, pricing, and reporting solution that helps to give everyone on the pharmaceutical continuum to see the impacts of pricing changes quickly and transparently. Truveris is backed by New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures, and First Round Capital.
- Headquarters New York, United States
- Employees 156
- SectorsHealthcare
- Website category Health · Pharmacy
- Website truveris.com
- Social LinkedIn X Facebook
- Legal Name Truveris Inc
- Total Equity Funding$68.7M (USD)
in 7 rounds
- Latest Funding Round$15M (USD), Series E
May 2024
- InvestorsNew Leaf Venture Partners
& 5 more
- Employee Count156
Products & Services of Truveris
Truveris offers a comprehensive portfolio of products and services, including Truveris Marketplace and truGuard.
Platform for accessing and selecting pharmacy benefit plans affordably.
Tool to monitor and manage pharmacy plan contracts effectively.
Funding Insights of Truveris
Truveris has successfully raised a total of $68.7M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $15 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $68.7M
- Total Rounds 7
- Last Round Series E — $15M
- Investors Count 6
All 7 funding rounds of Truveris with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $15M | Series E | – | New Leaf Venture Partners, Canaan | – |
| Aug 2017 | $24.68M | Series D | – | McKesson Ventures | |
| Mar 2016 | $2.47M | Series C | – | – | – |
| Jun 2014 | $12.75M | Series C | – | Canaan, Tribeca Venture Partners | – |
| Mar 2012 | $10M | Series B | – | New Leaf Venture Partners | |
| Feb 2011 | $3.8M | Series A | – | First Round Capital, Tribeca Venture Partners | – |
| Jun 2010 | Seed | – | NAV.VC | – |
6 investors in total: 6 institutional.
Investors in Truveris
Truveris has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include New Leaf Venture Partners, Canaan and McKesson Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Stage-agnostic investments in US life sciences are managed. | 2005 | nlvpartners.com | New York, United States | |
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
Investments are directed by McKesson Ventures toward early-stage healthcare startups. | ventures.mckesson.com | San Francisco, United States | ||
Early-stage VC firm investing in the US | tribecavp.com | New York, United States | ||
Investments are made in US seed and early-stage tech companies. | nav.vc | Reston, United States | ||
US focused seed and early-stage VC firm | firstround.com | San Francisco, United States |
Investor details for Truveris
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Truveris
4 people are tracked at Truveris (1 in leadership, 3 in team); the tracked headcount is 156.
| Name | Role | Group |
|---|---|---|
Garrett W. Fienberg | Chief Executive Officer | Leadership |
Kevin Burns | Principal Analyst | Team |
Nanette Oddo | Strategic Advisor | Team |
Christian Sawka | Senior Analyst | Team |
Complete people profiles for Truveris
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Truveris
3 dated milestones of Truveris across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Truveris is founded.
- Funding First funding round.
- Funding Latest funding round, Series E, of $15.0M.
Competitors of Truveris
Truveris has 3 listed competitors in our database, 1 of them funded. They include Express Scripts, Prescryptive Health and MedImpact Healthcare Systems.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| express-scripts.com | 1986 | St. Louis, United States | 16,291 | Pharmacy benefit management services are delivered through SaaS platforms. | ||
| prescryptive.com | 2017 | Redmond, United States | $26M | 49 | A platform for pharmacy benefit management solutions is provided. | |
| medimpact.com | 1989 | San Diego, United States | 1,824 | Pharmacy benefit management solution for payers, providers and employers |
Detailed competitors of Truveris
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Truveris
The website of Truveris (truveris.com) receives about 7K visits a month and ranks #3,040,452 among all websites worldwide, #3,661 in Pharmacy.
- Monthly visits7K
▲ 3.3% vs previous month
- Unique visitors3.1K
per month
- Global rank#3,040,452
among all websites
- Category rank#3,661
Health · Pharmacy
- Bounce rate42%
- Pages per visit1.7
- Average visit27 sec
- DevicesDesktop 43% · Mobile 57%
Websites whose visitors overlap most with Truveris. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mshp.org | mshp.org | 100% | #4,311,036 | – | |
lab.express-scripts.com | lab.express-scripts.com | 98% | – | ||
| organizedwisdom.com | 66% | View details | |||
quality-products.com | quality-products.com | 41% | – | ||
| rightwayhealthcare.com | 29% | 131.7K | #330,923 | View details |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Truveris (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Truveris
Complete news archive for Truveris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Truveris
Truveris was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Truveris is headquartered in New York, United States. It is registered at New York, New York, United States.
Garrett W. Fienberg is the CEO of Truveris, as recorded in our data.
Truveris is a funded company, having raised a total of $68.7M across 7 funding rounds to date.
Truveris has 156 employees.
HealthTech Analytics and Validation platform. A health information technology company delivering pharmacy data validation, analytics, and pricing solutions through a SaaS platform. Truveris products include TruGuard (claim validation), TruBid (online auction and RFP tool), and TruReport (prescription claim analytics). They also have a product called rxDash RxDash which is a pharmacy plan modeling, pricing, and reporting solution that helps to give everyone on the pharmaceutical continuum to see the impacts of pricing changes quickly and transparently. Truveris is backed by New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures, and First Round Capital.
Truveris's top competitors include Express Scripts, MedImpact Healthcare Systems and Prescryptive Health.
Truveris offers Truveris Marketplace and truGuard.
Truveris has 6 investors. Key investors include New Leaf Venture Partners, Canaan, McKesson Ventures, Tribeca Venture Partners, and NAV.VC.
Truveris operates through Truveris Inc.